Companion Diagnostics Market Analysis, Trends, Growth, Share and Forecast – 2027

Companion Diagnostics Market is expected to reach USD 6.8 billion by 2025 from USD 3.7 billion in 2020, at a CAGR of 12% during the forecast period of 2020 to 2025.

The benefits of companion diagnosis, the growing need for targeted therapy, the increasing importance of personalized medicine, increasing cancer incidence worldwide, and the ever-increasing application of companion diagnosis are driving the growth of the global companion diagnosis industry.

The key players profiled in this report include Abbott Laboratories Molecular, Inc., Agilent (Dako Denmark A/S), ARUP Laboratories, Inc., BioMerieux SA, Danaher Corporation (Leica Microsystems), Foundation Medicine, Inc., Myriad Genetics, Inc., Qiagen N.V., Roche (Ventana Medical Systems, Inc.),

Companion Diagnostics Key Market Segments:

By Product & Service

• Assays, Kits & Reagents

• Software & Services

By Technology

• Polymerase Chain Reaction

• Next-generation Sequencing

• In Situ Hybridization

• Immunohistochemistry

• Other Technologies

Scope of the Report
The research study analyzes the global Companion Diagnostics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Companion Diagnostics Market Report

1. What was the Companion Diagnostics Market size in 2018 and 2019; what are the estimated growth trends and market forecast (2019-2027).

2. What will be the CAGR of Companion Diagnostics Market during the forecast period (2019-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2018? How these segments are expected to grow during the forecast period (2019-2027).
4. Which manufacturer/vendor/players in the Companion Diagnostics Market was the market leader in 2018?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.